2026 ICD-10-CM Diagnosis Code T83.713SErosion of implanted urethral bulking agent to surrounding organ or tissue, sequela
T83.713S is a billable ICD-10-CM diagnosis code for erosion of implanted urethral bulking agent to surrounding organ or tissue, sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 922 through 923. The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Complication, sequela.
Code Identity
Code Classification
Present on Admission (POA)Billing
T83.713S is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.
Coding GuidelinesGuidance
The appropriate 7th character is to be added to each code from block Complications of genitourinary prosthetic devices, implants and grafts (T83). Use the following options for the applicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Convert T83.713S to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code History & ChangesHistory
Replacement T83.713S replaces the following previously assigned code(s):
- T83.718S - Erosion of implanted prstht mtrl to surrnd org/tiss, sequela
- T83.718S - Erosion of other implanted mesh to organ or tissue, sequela
Questions About T83.713SOverview
Is T83.713S a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report erosion of implanted urethral bulking agent to surrounding organ or tissue, sequela on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What does the 7th character S in T83.713S mean?
The final character S makes this a sequela code: it reports a lingering problem that remains after the erosion of implanted urethral bulking agent to surrounding organ or tissue itself has resolved, not the original event.
What MS-DRG does T83.713S group to?
When erosion of implanted urethral bulking agent to surrounding organ or tissue, sequela is the principal diagnosis on an inpatient stay, it groups to MS-DRG 922, 923, with relative weights from 1.0177 to 1.7494 depending on complications. Higher weights mean higher Medicare reimbursement.
Is T83.713S exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for erosion of implanted urethral bulking agent to surrounding organ or tissue, sequela on inpatient claims.
What is the ICD-9 equivalent of T83.713S?
Under the General Equivalence Mappings, erosion of implanted urethral bulking agent to surrounding organ or tissue, sequela converts to ICD-9-CM 909.3 (late eff surg/med compl). The mapping is approximate, so confirm the match fits the documentation.
